HNN3.0
Register
Register
Register

Healthentia

Company (SME)

healthentia.com/Brussels, Belgium
6 profile visits

About

Healthentia (known as Innovation Sprint Srl) is a Belgian digital health company developing a certified Software as a Medical Device (SaMD) platform for chronic disease management and clinical research. Founded with a strong background in medical technology, data science, and regulatory compliance, the company’s mission is to improve health outcomes by addressing the root causes of chronic diseases, particularly lifestyle and behavioral factors. Healthentia combines medical-grade rigor with scalable digital innovation, positioning itself at the intersection of healthcare delivery, remote monitoring, and digital therapeutics.

The Healthentia product is a Class IIa MDR-certified SaaS platform that integrates a patient mobile application with a clinical web dashboard. It enables continuous Remote Patient Monitoring (RPM) through validated connected devices, structured collection of patient-reported outcomes, and secure visualization of data for healthcare professionals. Beyond monitoring, Healthentia supports Digital Therapeutics (DTx) and virtual coaching, helping patients adhere to therapy, adopt healthier behaviors, and remain engaged in their care pathways.

Healthentia is deployed in hospitals, research projects, and real-world clinical settings across multiple countries. By combining regulatory-compliant medical modules with advanced behavioral change coaching and data analytics, Healthentia enables more proactive, personalized, and scalable care—supporting clinicians, empowering patients, and contributing to more sustainable healthcare systems.

Representatives

CEO

Healthentia

Marketplace (1)

  • Project cooperation

    Healthentia - a Class IIa MDR app for chronic disease patients

    Healthentia Class IIa MDR SaMD for clinical studies & chronic care, offering AI-powered lifestyle behavioral coaching.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    CEO at Healthentia

    Brussels, Belgium